These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 28402681)

  • 61. Dengue Virus Evolution under a Host-Targeted Antiviral.
    Plummer E; Buck MD; Sanchez M; Greenbaum JA; Turner J; Grewal R; Klose B; Sampath A; Warfield KL; Peters B; Ramstedt U; Shresta S
    J Virol; 2015 May; 89(10):5592-601. PubMed ID: 25762732
    [TBL] [Abstract][Full Text] [Related]  

  • 62. SELEX--a (r)evolutionary method to generate high-affinity nucleic acid ligands.
    Stoltenburg R; Reinemann C; Strehlitz B
    Biomol Eng; 2007 Oct; 24(4):381-403. PubMed ID: 17627883
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Searching for drug leads targeted to the hydrophobic cleft of dengue virus capsid protein.
    Ortlieb LO; Caruso ÍP; Mebus-Antunes NC; Da Poian AT; Petronilho EDC; Figueroa-Villar JD; Nascimento CJ; Almeida FCL
    J Enzyme Inhib Med Chem; 2022 Dec; 37(1):287-298. PubMed ID: 34894959
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Targeting the HIV-1 RNA leader sequence with synthetic oligonucleotides and siRNA: chemistry and cell delivery.
    Turner JJ; Fabani M; Arzumanov AA; Ivanova G; Gait MJ
    Biochim Biophys Acta; 2006 Mar; 1758(3):290-300. PubMed ID: 16337923
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Nongenetic Reprogramming of the Ligand Specificity of Growth Factor Receptors by Bispecific DNA Aptamers.
    Ueki R; Atsuta S; Ueki A; Sando S
    J Am Chem Soc; 2017 May; 139(19):6554-6557. PubMed ID: 28459560
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Designer DNA architecture offers precise and multivalent spatial pattern-recognition for viral sensing and inhibition.
    Kwon PS; Ren S; Kwon SJ; Kizer ME; Kuo L; Xie M; Zhu D; Zhou F; Zhang F; Kim D; Fraser K; Kramer LD; Seeman NC; Dordick JS; Linhardt RJ; Chao J; Wang X
    Nat Chem; 2020 Jan; 12(1):26-35. PubMed ID: 31767992
    [TBL] [Abstract][Full Text] [Related]  

  • 67. GTRV Summer School--Oligonucleotide-Based Strategies to Control Gene Expression: Delivery Issues. 6-8 September 2007, La Grande Motte, France.
    Vandenbroucke RE
    IDrugs; 2007 Nov; 10(11):778-81. PubMed ID: 17968757
    [No Abstract]   [Full Text] [Related]  

  • 68. Aptamers: prospects in therapeutics and biomedicine.
    Yan AC; Bell KM; Breeden MM; Ellington AD
    Front Biosci; 2005 May; 10():1802-27. PubMed ID: 15769669
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Application of Aptamers in Virus Detection and Antiviral Therapy.
    Zou X; Wu J; Gu J; Shen L; Mao L
    Front Microbiol; 2019; 10():1462. PubMed ID: 31333603
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Aptamer-associated colorimetric reverse transcription loop-mediated isothermal amplification assay for detection of dengue virus.
    Arruda VdO; Filho LRG; Neves AF
    Microbiol Spectr; 2024 Sep; 12(9):e0358323. PubMed ID: 39046260
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Development of a Molecular Aptamer Beacon Applied to Magnetic-Assisted RNA Extraction for Detection of Dengue and Zika Viruses Using Clinical Samples.
    da Silva AG; Goulart LR; Löffler P; Code C; Neves AF
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430340
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Aptamers in Virology-A Consolidated Review of the Most Recent Advancements in Diagnosis and Therapy.
    Yadavalli T; Volety I; Shukla D
    Pharmaceutics; 2021 Oct; 13(10):. PubMed ID: 34683938
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Oligonucleotide aptamers for pathogen detection and infectious disease control.
    Wan Q; Liu X; Zu Y
    Theranostics; 2021; 11(18):9133-9161. PubMed ID: 34522231
    [TBL] [Abstract][Full Text] [Related]  

  • 74. RNA aptamers for AMPA receptors.
    Huang Z; Niu L
    Neuropharmacology; 2021 Nov; 199():108761. PubMed ID: 34509496
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Aptamers isolated against mosquito-borne pathogens.
    Navien TN; Yeoh TS; Anna A; Tang TH; Citartan M
    World J Microbiol Biotechnol; 2021 Jul; 37(8):131. PubMed ID: 34240263
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Aptamers for Anti-Viral Therapeutics and Diagnostics.
    Kim TH; Lee SW
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920628
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The RNA secondary structural variation in the cyclization elements of the dengue genome and the possible implications in pathogenicity.
    Mishra B; Balaji A; Beesetti H; Swaminathan S; Aduri R
    Virusdisease; 2020 Sep; 31(3):299-307. PubMed ID: 32904896
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Developing RNA aptamers for potential treatment of neurological diseases.
    Huang Z; Niu L
    Future Med Chem; 2019 Mar; 11(6):551-565. PubMed ID: 30912676
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Characterization of oligonucleotide aptamers targeting the 5'-UTR from dengue virus.
    Cnossen EJ; Silva AG; Marangoni K; Arruda RA; Souza EG; Santos FA; Fujimura PT; Yokosawa J; Goulart LR; Neves AF
    Future Med Chem; 2017 Apr; 9(6):541-552. PubMed ID: 28402681
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Interactions between the Dengue Virus Polymerase NS5 and Stem-Loop A.
    Bujalowski PJ; Bujalowski W; Choi KH
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28356528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.